Mini-Gastric Bypass

The Mini-Gastric Bypass Surgery


Short, Simple, Effective

Short, Simple, Effective Weight Loss Surgery

Lap AGB

Home Up Patient Emails Search Contact Us Compare MGB

Call Dr. Rutledge 702-714-0011 or Email: DrR@clos.net

Call Dr. Peraglie 407-922-3424 or Email: DrP@clos.net

Follow Us on FaceBook

Watch Our Videos on YouTube

Follow Us on Twitter

Start Here

Win Free iPad
Follow Up

Talk with 1,000s
of MGB patients

Join Us on FaceBook or Myspace

Chat with
MGB patients

Patient
Application
Form

Watch MGB
Animation

Watch 100s
of Videos

Got Lap-Band
Problems?

How Much
Does it Cost

Best Weight
Loss Surgery

$9,500
Same Day MGB

Search

Mailing List

Pictures

MGB Papers

Daily Emails

PreOp
Process

MGB Manual

Meet Our
Patients

Patient
Application

THE Notebook!

MGB Video

Our Brochure

Search

Follow Up

MGB vs RNY

Research

Take Survey

Discharge
Instructions

Home
Up

45. Silicone Adjustable Gastric Banding For Morbid Obesity. Systematic Review Update, Jan. 1999-May 2000

Horacio E Oria, MD, FACS Private Practice, Spring Branch Medical Center, Houston, TX, USA

Background'. A systematic analysis of the literature on adjustable gastric banding (1966 to Dec. 1998) was presented at several meetings and published in Obes Surg 1999; 9: 133-4. The main conclusion was that the data was insufficient to analyze objectively the merits of this technique. Although manufacturing- related problems and intraoperative complications had diminished overtime, the incidence of complications and reoperations remained high. Moreover, long-term follow-up and data on weight-loss were inadequate. This update compiles the recent publications, compares the data with the previous review, and analyzes the quality of the papers and reporting of outcomes.

Methods: Publications in English were identified through a MEDLINE (Jan.1999-May 2000) literature search. The inclusion and exclusion criteria were the same as in the first review. A minimum of 40 cases and 1 year of follow-up was required, as well as data on technique, early and late morbidity, mortality, reoperations and weight loss. The latest paper by the same authors was selected. Poster presentations and videos were not included. Two Italian registries series will be discussed separately. The outcomes were tabulated, summarized and compared with the information collected for the first analysis.

Results: 166 studies (43 articles,123 abstracts) were reviewed. Obesity Surgery published 102. Other 54 were mostly abstracts from the 1st. ISLOS meeting (Naples, Italy, 1999). Only 10 appeared in other journals. Alarmingly, 35 papers (21%) dealt specifically with complications of this technique. Inclusion criteria were met in 38 publications. Repeated presentations were excluded, leaving 23 studies from 11 countries for final analysis. A total of 4956 patients (82% females) were operated, 88% by laparoscopy. The American-made adjustable band was used in 76.3%, the Swedish in 15.4%. Unknown type of band in 6.8%, InamedR in 1.5%. BMI: 44.3 (42-47.8) Conversion: 4.5% (0-23.6). Complications, mean(range): Gastric perforation: 1% (0-4) - Bleeding: 0.8% (0-4) - Other intraop. complications: 0.5% (0-1.3) - Medical postop. complic. 0.6-23% - Mortality: 0.4% (0-3.3). Cumulative abdominal reoperation rate: 10.5% (Revision: 5.3% - Reversal: 2.5% - Other: 1.4% - Gastric incorporation of band: 1.3%). Port/catheter: 3.8% (0-10.4). Follow-up time1weight loss (n= publications reporting): Mean F/U period: 23 months (6). Per cent of patients followed: >90% (6). Mean excess weight loss at 24 months: 61% (7), 36 m.: 56.7% (4), >36 months: 50.3% (1). Only 10, 6 and 1 publications reported weight loss at 24, 36 and >36 months, respectively. The results are very similar to the 1 st. review.

Conclusions: The number of operations has increased, as well as the rate of publications. Obesity Surgery continues to be the premier source of information. The quality of the publications has improved, although only 3/23 had the information readily available and well organized. Several articles showed data contradictions in between the abstract and the text. The mean BIVII is lower than most American series. The majority of the papers selected have <200 patients and very short follow-up. Complication, reoperation, port/catheter problem and mortality rates have not changed overtime. Although the new adjustable devices have been used for >1 0 years, long-term follow-up, analysis of late complications and weight loss reporting continues to be unsatisfactory. The newly published data is again insufficient to judge the merits of the procedure. In view of the results of this updated review, bariatric surgeons need to moderate their enthusiasm, study the information available and conduct proper scientific trials to objectively evaluate the outcomes of this novel technique.

Home Up Patient Emails Search Contact Us Compare MGB
This notice describes how information about you may be used and disclosed and how you can gain access to this information.  Please review carefully


Contact Information: -Telephones: *** CLOS West: 702-714-0011, *** CLOS Florida: Flo Ballengee 863-899-3463, Dr. Peraglie 407-922-3424


Email Us Anytime for Help:
Email: Everyone@clos.net or CLOSLasVegas@clos.net *** CLOS West DrR@clos.net, or CLOSLasVegas@clos.net *** CLOS Florida: Flo Ballengee Flo@clos.net, Dr. Peraglie DrP@clos.net


Addresses:
Address: *** CLOS West: Dr. Rutledge / CELOS, 98 E Lake Mead Parkway, Suite 302, Henderson NV 89015, Telephone: 702-714-0011 Fax: 702-456-1173, Email: DrR@clos.net, Everyone@clos.net or CLOSLasVegas@clos.net *** CLOS Florida: 40124 Highway 27, Suite 203, Davenport, FL 33837, Flo Ballengee 863-899-3463, Flo@clos.net, Dr. Peraglie 407-922-3424 DrP@clos.net


Warning: Gastric Bypass Surgery is a MAJOR surgical procedure. It can be associated with significant risks and complications, up to and including death. Weight loss surgery is a rapidly developing area of medicine. Bariatric surgery is filled with controversy. It is very important to take a careful and deliberate approach to considering surgery for the treatment of obesity.  

Disclaimer Notice:-Information on this web site is provided for informational purposes only.
-It is imperative that you consult your own physician regarding the applicability of any opinions or recommendations with respect to your symptoms or medical condition.
-Contact with this web site or Dr. Rutledge over the web site does not constitute a doctor patient relationship and for good quality medical care you must obtain advice and consultation form your own local physician.
-This site is intended as a resource for references on the treatment of obesity for health care professionals and educated consumers.
-The authors and editors have used sources believed to be reliable in their efforts to provide information that is complete and generally in accord with the standards accepted at the time of publication.
-Medical knowledge changes rapidly. In view of the possibility of human error or changes in medical science, neither the authors nor the editors nor any other party who has been involved in the preparation or publication of this work warrants that the information contained herein is in every respect accurate or complete, and they are not responsible for any errors or omissions or for the results obtained from the use of such information.
This information is not medical advice or diagnosis, nor is it to be construed as medical advice, medical information, medical diagnosis, or medical prescription for curing, removing, or preventing any disease, or related symptoms. You must seek the direct assistance, advice and evaluation of your own personal physician before acting on any information found herein. These statements have not been evaluated by the Food and Drug Administration.
-Readers are Strongly encouraged to discuss and confirm the information contained herein with your own physician.
Copyright © 1998 The Center for Laparoscopic Obesity Surgery